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Manual and automated solvent-free mini-ball mill (MBM) matrix-assisted laser desorption/
ionization (MALDI) analysis of mixtures of -amyloid peptides (1-11), (33-42), (1-42) and
non--amyloid component of Alzheimer’s disease peptide yielded interpretable spectra for all
of the peptides present regardless of their relative amounts in the samples. This was not the
case for solvent-based MALDI analysis using traditional acidic aqueous/organic solvent
conditions, which resulted in severe over-representation of hydrophilic peptide (1-11) and
provided no spectra for insoluble amphiphilic peptide (1-42) even when present at 50% relative
molar amount. Less accurate representation of components in mixtures by the traditional
method appears to be a combination of poor dissolution of peptides in the solvent and
preferential ionization of more hydrophilic peptides in the mixture. Consequently, only MBM
provided a complete tryptic map of -amyloid (1-42) compared to 67% coverage by traditional
MALDI. Acetonitrile (0.1% TFA) led to improved coverage only at a 50%molar ratio of peptide
(1-42), but also to a side product of (1-42), Met oxidation (amino acid 35), a phenomenon not
observed in MBM MALDI analysis. Traditional MALDI analysis resulted in over-representa-
tion of hydrophilic soluble -amyloid (1-11) in defined mixtures and autoproteolytic peptides
of trypsin. In contrast, over-representation and under-representation were less pronounced in
solvent-free MALDI in all of the investigated cases. Analysis of defined peptide and tryptic
peptide mixtures showed that MBM MALDI yielded greater qualitative reliability, which also
improved quantitative response relative to the solvent-based approach. (J Am Soc Mass
Spectrom 2007, 18, 1533–1543) © 2007 American Society for Mass SpectrometryEvading solvent-mediated changes, e.g., segrega-tion and side-reactions, to the sample whileachieving excellent sensitivity and resolution us-
ing the solvent-free matrix-assisted laser desorption/
ionization (MALDI) mass spectrometry (MS) method
are important advantages for the analysis of synthetic
polymers and other large synthetic macromolecules
even when solubility restrictions apply [1–3]. However,
the method is potentially as important for the analysis
of peptide molecules that in many cases are intractable,
such as peptides derived from membrane proteins. The
current study seeks to determine if the mini-ball mill
(MBM) MALDI-MS method [4] can representatively
analyze sample mixture components as well as or better
than the conventional solvent-based MALDI method. A
common case where mixture analysis is important is in
analyzing components of a tryptic digest. -Amyloid
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doi:10.1016/j.jasms.2007.04.017(1-42), (Scheme 1), comprises a particularly good test
since its tryptic digests are expected to contain a mix-
ture with components of widely varying hydrophobic-
ity [5]. This solubility-restricted, aggregating biopoly-
mer [6, 7] is amphiphilic (Scheme 1), and has a
hydrophilic N- and a hydrophobic C-terminus. -Amy-
loid (1-42) is an enzymatic cleavage product of the
amyloid-precursor protein (APP). APP processing and
the role of cerebral amyloid  accumulation in common
forms of Alzheimer’s disease (AD) have been exten-
sively studied and reviewed; for brevity only one
reference is cited [5].
Experimental
Materials
-Cyanohydroxycinnamic acid (HCCA) was purchased
from Sigma-Aldrich (St. Louis, MO). -Amyloid (33-42;
MWaverage (average molecular weight) 915.2 Da) 1,
-Amyloid (1-11; MWaverage 1325.3 Da) 2, non--
amyloid component of Alzheimer’s disease (NAC;
MWaverage 3260.6 Da) 3, and -amyloid (1-42; MWaverage
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1534 TRIMPIN AND DEINZER J Am Soc Mass Spectrom 2007, 18, 1533–15434515.1 Da) 4 were obtained from American Peptide
Company (Sunnyvale, CA). Sequencing-grade trypsin
along with its suspension buffer (Promega, Madison,
WI) was used for digestion experiments. High purity
water (Burdick and Jackson, Muskegon, MI), acetoni-
trile (ACN) (J. T. Baker, Philipsburg, NJ), and trifluoro-
acetic acid (TFA) (Sigma Chemicals Co., St. Louis, MO)
were used for dissolving samples.
MALDI-TOF Analysis
MALDI-time-of-flight-mass spectrometry (TOF-MS) was
performed on an ABI4700-TOF/TOF mass spectrometer
(Applied Biosystems, Framington, MA) with an accelerat-
ing voltage of 20 kV. Samples were placed on a standard
192-well stainless steel sample plate, dried if needed
(solvent-based approach), and excess powder removed
using a difluoroethane duster canister (Dust-Off, Willis-
ton, VT). Data were acquired in the reflectron mode. Mass
spectra were calibrated using standards supplied with the
Applied Biosystems ABI4700 CalMix. Experimental con-
ditions (e.g., laser power) were kept constant throughout
to ensure relevant comparisons within specific sets of
experiments. The conditions were set so that individual
peptide signals with good intensities but minimum detec-
tor saturation resulted for asmanymixture components as
possible. However, sample preparation (solvent) and laser
H-Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-
Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-
Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-
Gly-Leu-Met-Val-Gly-Gly-Val-Val-Ile-Ala-OH
(1-11) 2: 1325.3 Da, soluble
(33-42) 1: 915.2 Da, solubility-restricted
(1-42) 4: 4151.1 Da, solubility-restricted
H-Glu-Gln-Val-Thr-Asn-Val-Gly-Gly-Ala-Val-Val-
Thr-Gly-Val-Thr-Ala-Val-Ala-
Gln-Lys-Thr-Val-Glu-Gly-Ala-Gly-Ser-Ile-Ala-
Ala-Ala-Thr-Gly-Phe-Val-OH
NAC 3: 3260.6 Da, soluble
Scheme 1. Primary amino acid sequences of amyloid-precursor
protein (APP) peptides 1 to 4: primary amino acid (aa) sequences,
average molecular weight (MWaverage), and solubility in aqueous
solution.power conditionswere altered in solvent-basedMALDI todetermine whether or not analysis can be improved in
cases of detection failure under the previous set of condi-
tions. For automated mass measurement analysis, an
inclusion list was used for both preparation methods. The
list determines which signal should be used for MS/MS
analysis if detected in the initial mass spectrum.
Sample Preparation
I. Solvent-free based on the mini-ball mill (MBM)
method. A general solvent-free protocol was used [4].
Mixing of the analyte and matrix powder was per-
formed using a mini-beadbeater (Biospec Products,
Bartlesville, OK) with a mixture of beads in plastic tubes
(0.2 mL PCR tubes; Molecular Bioproducts, San Diego,
CA). In Exp. 1 and 2, three metal beads (1.2 mm size;
Biospec Products) were used. The rationale for the use
of metal beads was to avoid any metal cation sources.
Alternatively, in Exp. 3, glass beads in 0.5 mm and 1.0
mm sizes (Biospec Products), were employed. The
amount of beads used corresponded roughly to the
volume of the MALDI sample already present in the
tube. If drying procedures were involved, the matrix
was added to the analyte that was dried over the beads.
The capped tube was placed in the original MBM
container and placed in the two-dimensional shaker
arm of the MBM and shaken for the desired length of
time. A minimum amount of the ground powder was
applied to the MALDI plate and spread carefully over
several spots and affixed by pressing with the flat edge
of a spatula. Estimate amounts of sample transferred to
the MALDI plate are 1/20th of the finely distributed
MBM material in the 200-L vial providing coverage of
about two to five MALDI spots.
II. Solvent-based method. For the solvent-based method,
2 mg -cyano-4-hydroxycinnamic acid (HCCA) was
dissolved in 1 mL 50:50 acetonitrile (ACN):water 0.1%
trifluoroacetic acid (TFA), a solvent system generally
used in traditional solvent-based MALDI analysis; 1.5
L of the matrix solution were combined with 0.5 L of
the dissolved sample and mixed in the vortexer for 10 s;
0.5 L was placed on the MALDI plate. Solvents used to
dissolve the model peptide mixtures were 50:50 ACN:
water 0.1% TFA or 99.9% ACN 0.1% TFA; the tryptic
digested sample was used as is. Dissolved sample was
placed on the MALDI plate and evaporated.
Experimental Details
Experiment 1. For tryptic digestions, 1 to 5 L of 1 g
L1 trypsin in a suspension buffer were added to 100
g -amyloid 1 dissolved in 100 to 200 L water and
the digestion mixture was placed on a 37 °C shaking air
bath overnight. Tryptic peptides were generated (A)
overnight for solvent-based MALDI- and electrospray
ionization (ESI)-quadrupole-time-of-flight (Q-TOF)-MS
and MS/MS analyses; 100 g were dissolved in 100 L
water, 5 L trypsin solution was added for digestion or
tide o
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free MALDI- and ESI-Q-TOF-MS and MS/MS analyses;
100 g were dissolved in 200 L water, 1 L trypsin
solution was added for digestion. In general, more
dilute solutions of 4 produced improved digestion with
less autoproteolysis of trypsin. Additionally, 4 was
denatured by incubation at 100 °C for 5 min. After
cooling, trypsin was added and digestion was carried
out for 3 and for 24 h.
General. After proteolytic digestion of 4, an aliquot
was taken for solvent-based MALDI analysis. The re-
maining sample was frozen by liquid N2 and then
freeze-dried to obtain MBM analysis. MS and MS/MS
spectra of the digest of 4 were recorded.
Experiment 2. A model complex mixture of insoluble
peptides 1 and 4, and soluble peptides 2 and 3weremixed
in amolar ratio of about 1:1:1:1 (Mix. 1) for peptides 1:2:3:4
and investigated by solvent-free and solvent-based
MALDI methods. Additional mixtures, 3:3:3:1 (Mix. 2)
and 1:1:1:3 (Mix. 3), were prepared accordingly. Exact
values of molar peptide ratios of defined peptide mixtures
are provided in Table 1. Peptide mixtures were transferred
on a weighing foil to the MBM plastic tube (0.2 mL) and
vortexed with three metal beads to homogenize the pep-
tide sample within the tube. In both steps solvent was
omitted to avoid preferential dissolution of soluble pep-
tides. Matrix was initially left out when homogenizing the
four peptides to prevent adduction with alkali metal
cations to the peptides, which had previously been shown
to increase with increasing grinding time when matrix is
present [4]. Homogenized peptide samples were then
Table 1. Response factors of -amyloid peptides 1:2:3:4:(molar r
MALDI-TOF mass spectra using solvent-based and solvent-free M
Mix. no. Peptides
Peptide ratios So
Molar Percent
Signal
intensity1
P
t
1 (33–42) 1 0.99 24.6 0.22
(1–11) 2 1.05 26.1 3.59
NAC 3 0.98 24.4 0.21
(1–42) 4 1 24.9 n.s.
2 (33–42) 1 3 30 0.1
(1–11) 2 3 30 9.19
NAC 3 2.99 29.9 0.7
(1–42) 4 1 10 n.s.
3 (33–42) 1 0.9 14.8 0.12
(1–11) 2 1.18 19.4 5.66
NAC 3 1.01 16.6 0.31
(1–42) 4 3 49.3 n.s.
n.s. No signal. The signals were either too weak, non-descript or non-e
n.a. Not applicable.
1Signal intensities are the sum of the signal cluster areas of protonated
mass spectrum (Supplementary Information) is: (A) solvent-based: Mix.
2: 1.8 e4; Mix. 3: 1.3 e4.
2Response factor is the ratio of the percent of total signal for each pepindividually mixed with HCCA matrix according to theMBM procedure (1 min) described above. Sample prepa-
ration might have introduced small systematic error(s) if
not all of the powder came off of the foil when homoge-
nizing solely the peptides or subsequently peptides with
the matrix. Nevertheless, the homogeneity achieved for a
given peptide mixture will be the same in solvent-free and
solvent-based MALDI experiments; so that a comparison
of results between the traditional solvent-based and sol-
vent-free MALDI analysis for any given sample is as-
sumed to be accurate. Mixtures 2 and 3 were vortexed
longer to insure homogeneity before the HCCA matrix
was added. Resulting MALDI samples were (1) applied
directly to the MALDI plate (solvent-free MBM MALDI),
or (2) completely dissolved in 50:50 ACN:water 0.1% TFA
and applied to the MALDI plate (solvent-based MALDI),
or (3) dissolved in ACN 0.1%TFA solution in an effort to
dissolve the in aqueous solution insoluble peptides 1 and
4 for solvent-based MALDI analysis.
Experiment 3. A 6.0 pmol L1 solution of peptide
(1-11) 2was serially diluted to make solutions of 3.0, 1.5,
0.75, 0.375, and 0.187 pmol L1. 100 L of each
solution was used with the MBM solvent-free MALDI
method to determine the lowest detectable peptide
amount required per vial; the amount transferred to the
MALDI plate is estimated to be 1/100th of the total.
LC-ESI-MS
LC-MS/MS employed a Waters (Millford, MA) CapLC
connected to a Waters Q-TOF Ultima Global. 2-6 l of
sample were loaded onto a Waters Symmetry C18 trap
at 4 L min1, then the peptides were eluted from the
) in defined mixtures: (1) 1:1:1:1, (2) 1:1:1:1, and (3) 1:1:1:3 in
MALDI-MS preparation methods
t-based Solvent-free
nt of
ignal
Response
factor2
Signal
Intensity
Percent of
total signal
Response
factor2
47 0.22 0.52 12.9 0.52
3 3.42 2.93 72.9 2.79
22 0.21 0.18 4.48 0.18
s. n.a. 0.39 9.7 0.39
0.03 2.11 21.1 0.7
3.07 6.75 67.5 2.25
0.23 0.79 7.9 0.26
s. n.a. 0.35 3.5 0.35
97 0.13 0.76 12.5 0.85
9 4.8 4.44 73 3.76
09 0.31 0.4 6.58 0.4
s. n.a. 0.48 7.89 0.16
nt to be measured.
iated, potassiated, and doubly charged ions. Total ion current for each
e4; Mix. 2: 1744.6; Mix. 3: 5572.2; (B) solvent-free: Mix. 1: 3384.9; Mix.
ver the percent of peptide present (by weight).atios
BM
lven
erce
otal s
5.
89.
5.
n.
1
92
7
n.
1.
92.
5.
n.
xiste
, sod
1: 1.7trap onto the 10 cm  75 m lab packed Phenomenex
1:1:1
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CA) at 300 nl min1. The precursor ions of peptides
eluting from the analytical LC column were monitored
using 0.6 s scans from m/z 500 to 1990. Up to three
parent ions per survey scan that had sufficient intensity
and had up to three positive charges were chosen for
MS/MS. The MS/MS scans were 2.4 s from m/z 50 to
1990. The mass spectrometer was calibrated using the
MS/MS spectrum of glu-fibrinopeptide. Masses were
corrected during each run using a lock mass scan every
30 s of glu-fibrinopeptide.
Data Analysis
MASCOT (Matrix Science, London, UK) was used to
score and interpret the tandem mass spectral data for
the peptides [8]. The following restrictions were used:
precursor and MS/MS tolerance of 0.5 Da, peptide
charge 1 for MALDI, in general 2 and 3 for ESI,
and modifications were limited to the parameters sodi-
ated (amino acids D, E), sodiated (C-terminus of a
peptide), and oxidation (amino acid M).
Computational Analysis of Peptide Properties
Grand average of hydropathicity (GRAVY) scores (Ta-
ble 2) of peptides 1 to 4 were determined using the
database supplied by the Swiss Institute of Bioinformat-
ics at http://us.expasy.org/tools/protparam.html.
Results and Discussion
Tryptic Peptide Mapping Investigations of Peptide
(1-42) Using Solvent-Based MS Methods
Solvent-based MALDI analysis of the tryptic peptides
of 4 yielded MS and MS/MS spectra (Exp. 1A) with
good signal intensity. However, only the more soluble
tryptic peptides of 4 could be recorded and identified
(Table 3). None of the hydrophobic C-terminal tryptic
peptides, T6-42, T17-42, or T29-42, were detected. This
result indicates that the hydrophobic tryptic peptides
from tryptic digestion of (1-42) might be detected less
favorably under conditions (50:50 ACN:water 0.1%
Table 2. MASCOT ion scores of data obtained in the automated
peptide mixtures 2 and 3 studied by two different MALDI metho
obtained from http://us.expasy.org/tools/protparam.html are pr
Average molecular
weight in Da
Solubility in
aqueous solution1
GRAV
score2
Peptide 1 915.2 Low 2.133
Peptide 2 1325.3 High –1.782
Peptide 3 3260.6 High 0.726
Peptide 4 4515.1 Low 0.162
1Solubility according to suppliers’ information and e.g., [16].
2Grand average of hydropathicity (GRAVY) index.
3,4Compositions: Molar ratios of peptides 1:2:3:4 of 3:3:3:1 (Mix. 2) andTFA) commonly employed in traditional solvent-basedMALDI analysis. Sequence coverage of 4 was 66.7%,
which corresponds to the coverage of just the soluble
N-terminal region amino acids (aa) 1 to 28. Abundant
additional signals were observed at m/z 2211 Da, corre-
sponding to peptides formed in trypsin self-digestion,
and at m/z 2543 Da and m/z 4512 Da corresponding to
doubly and singly charged undigested 4, respectively.
These latter signals suggest that a large amount of
peptide 4 remained undigested, which, from a biologi-
cal perspective, is not unexpected considering its poor
solubility, high aggregation tendency, and ability to
inhibit trypsin digestion [6]; however, this cleavage
specific protease was used throughout this work to
keep a maximum degree of confidence in data interpre-
tation. The detection of the large insoluble peptide 4
coupled with the failure to observe the smaller insolu-
ble peptides T17-42 and T29-42 was unexpected.
Quantitative representation of peptides in the com-
plex mixture, in particular peptides with limited solu-
bility, was not obtained using the solvent-based MALDI
method. In the tryptic digestion of 4, peptides are
produced that show very different solubilities (Scheme
1, Table 2). When molar ratios in the solutions are
shifted towards the soluble peptides, the characteriza-
tion of the less soluble ones becomes increasingly
difficult. Thus, if solvent-based MALDI is employed,
approaches to keep the less soluble peptides in solution
may need to be involved. In earlier work, detergents
were employed to keep the hydrophobic and/or solu-
MS measurements of the individual peptides from model
olubility in aqueous solution, and hydropathicity index
ed
Mix. 23 Mix. 34
olvent-based Solvent-free Solvent-based Solvent-free
n.a. 82 n.a. 95
74 65 75 56
40 74 45 56
n.a. 12 n.a. 18
:3 (Mix. 3).
Table 3. Trytpic peptides of amyloid (1–42) 4 according to
their MS signal intensities using solvent-based MALDI as well
as MASCOT ion scores derived from MS/MS data (all data
available in the Supplementary Information section). Tryptic
autoproteolysis has been observed to 2% (m/z 2211)
m/z [Da] z1
Signal
intensity MASCOT ion score
T1-16 1954.9 1 4140 88
T1-42 4512.1 1 1863 n.a.
T6-16 1336.6 1 1035 78
T1-42 2257.6 2 517 n.a.
T6-28 2642.2 1 310 36
T1-16 977.9 2 207 n.a.MS/
ds; s
ovid
Y
Sn.a. not applicable.
the
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trometric analysis is in general very sensitive to addi-
tives like detergents, therefore, are more likely to be
removed by, for example, hyphenated liquid chroma-
tography (LC)-MALDI or LC-ESI approaches.
LC-ESI (see Supplementary Information section,
which can be found in the electronic version of this
article) of the tryptic digest of 4 also showed peptide
peaks, thus confirming that some digestion had oc-
curred, but their relatively low signals strongly sug-
gests that 4 was largely undigested. In addition, the MS
andMS/MS data interpreted by MASCOT showed only
signals for peptides within aa residues 6 to 28 with
peptide T6-28 and peptide T17-28 giving MASCOT scores
of 51 and 84, respectively, thus providing high confi-
dence peptide identification (expectation values of up
to 1.7e-6) with a sequence coverage of 54.8%.
Peptides that contain aa residues 29 to 42 were not
MS accessible and therefore the entire sequence of
-amyloid peptide 4 could not be identified manually
or through MASCOT interpretation. The poor detection
of T17-42 is probably a combination of this peptide not
being protonated in sufficient amounts when either
solvent-based MALDI or ESI is used and its poor
solubility. To the best of our knowledge there is no MS
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Figure 1. Mass spectra of tryptic digest of 4
analysis. Only the MBM approach detects the hy
and metal adducted, peptide T17-42 (m/z 2598). In
auto-proteolysis product, is observed, but not indata available on tryptic digested -amyloid peptide(1-42) but there is for -amyloid peptide (1-40) [13];
-amyloid peptide (1-42) has a higher tendency of
aggregation than -amyloid peptide (1-40) [7]. These
previous tryptic peptide mapping results of (1-40) re-
vealed the ESI-MS detection in the following chromato-
graphic order: T6-16, T1-5, T1-16, T17-28, T1-40, T6-40, and
T6-40 in which the latter three peptides were not chro-
matographically resolved.
The results of the solvent-based MS investigations
sought to study in-depth the differences in solvent-
based and solvent-free MALDI by varying digestion
procedures of -amyloid peptides (1-42) 4 and by
preparing defined mixtures of -amyloid peptides (33-
42) 1, (1-11) 2, (1-42) 4, and non--amyloid component
of Alzheimer’s disease peptide (NAC) 3.
Direct Comparison of Tryptic Peptide Mapping
Investigations of Peptide (1-42) Using Solvent-
Based ESI and MALDI and Solvent-Free MALDI
Methods
To be certain that all peptides were formed in sufficient
amounts, the digestion procedure for 4 was altered to
include a denaturation step. After 3 h, the solvent-based
3252 4126 5000s (m/z)
1250.6
45
12
.5
3252 4126 5000s (m/z)
3088.7
45
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.7
[M
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+
H
]+
17
-4
2
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+
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solvent-based, (B) solvent-free MBM MALDI
hobic, solubility limited C-terminal, protonated
solvent-based spectrum, m/z 2211 Da, a trypsin
solvent-free sample preparation method.Mas
25
98
.6
Mas
T
: (A)
drop
theMALDI mass spectra showed one intense signal at m/z
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with low intensity at m/z 1336.6 Da corresponding to
sequence T6-16, and little else. After 24-h (Figure 1a, Exp.
1B), digestion had proceeded further, but undigested 4
was still detected. The solvent-based MALDI MS
method again yielded 66.7% sequence coverage, con-
firming the previous solvent-based results. The relative
signal intensities in the solvent-based MALDI mass
spectrum were in the order T1-16, followed by T6-16, T1-5,
and a very weak T17-28. The signal intensity of undi-
gested 4 (z  1, 2) is significantly smaller than observed
in the sample that was not denatured before proteolysis
(Table 3), indicating that the digestion degree had
increased. LC-ESI results detected peptide T17-28 with
MASCOT ion scores up to 84 providing sequence
coverage of 28.6% (see Supplementary Information sec-
tion for chromatograms, mass spectra, and MASCOT
ion scores under various conditions); trypsin autopro-
teolysis was also observed. Overall, LC-ESI analysis
was more involved in sample handling, e.g., column
plugging, and results were based on sequence coverage
of less quality than solvent-based MALDI.
The solvent-free MALDI method has been shown to
be capable of analyzing solubility-limited macromole-
cules [1–3], and therefore this approach might be ex-
pected to provide spectra for the insoluble amyloid
peptides. Solvent-free MBM (Figure 1b, Exp. 1B) not
only displayed intense signals for all the tryptic pep-
tides of 4 recorded by solvent-based MALDI, but in
addition displayed a T17-42 signal with high intensity
that provided 100% sequence coverage. Undigested 4 (z
 1) was also detected, but trypsin autoproteolysis
products were not observed. This seems to be in accord
with the 1:500 trypsin to -amyloid 4 ratio used for
proteolysis. Based on these MALDI results as well as
the LC-ESI result discussed above, the solvent-based
analysis over-represents the trypsin self-digestion pep-
tides. A high degree of sodiated parent ions accompa-
nied the solvent-free analyses; the higher metal adduc-
tion tendency of the solvent-free versus the solvent-
based approach was described previously [4, 14].
Generally, the most intense signal for the individual
peptides were those of the protonated parent ion, e.g.,
[T6-16  H]
; only the C-terminal peptide appeared
predominantly as the sodiated ion [T17-42  Na]
. The
source(s) of sodium ions has not been fully established
but the matrix may be a major contributor [4].
Qualitative Assessment of the MS and MS/MS
Analyses of Defined Peptide Mixtures
To better understand the differences observed between
the solvent-based and solvent-free approaches, sets of
defined peptide mixtures were studied. The peptide
mixtures, Mix. 1 to 3, employed the same -amyloid
peptides (33-42) 1, (1-11) 2, (1-42) 4, and (NAC) 3 in
different molar ratios. Aqueous soluble peptides, 2
(MWaverage  1325) and 3 (MWaverage  3261), and theless insoluble peptides, 1 (MWaverage  915) and 4
(MWaverage  4515) (Exp. 2) were mixed in a 1:1:1:1
molar ratio (Mix. 1, Table 1). A portion of the solvent-
free MBM sample was dissolved in 50:50 ACN:water
0.1% TFA and used for solvent-based MALDI.
Only soluble peptides, 2 and 3 (Figure 2, Inset 2A
and 3A), and low molecular weight hydrophobic pep-
tide 1 (Figure 2, Inset 1A, were detected by the solvent-
based method while all peptides were detected in the
solvent-free MALDI spectra (Figure 2, Inset 1– 4B) with
excellent shot-to-shot reproducibility. The higher mo-
lecular weight soluble peptide 3 was observed in lower
abundance compared to the soluble lower molecular
weight peptide 2 (Figure 2, Inset 2, 3B).
The degree of alkali metal adduction and exchange
were high in both MALDI methods for the most hydro-
phobic peptide 1. The solvent-free method, as noted
above, tends to promote metal adduction (Figure 2) for all
peptides, giving a ratio of about 10:8:3 (proton:sodium:
potassium cations) compared with 10:1:3 using the
solvent-based method for peptide 3. Cation adduction
was advantageous in the case of peptide 1, which has no
hydrophilic sites for protonation and yet a signal could be
observed because of the adduction. However, the molec-
ular ion signal for the peptide is distributed over different
ions, including protonation and various different metal
cation adductions, all of which are of low abundance.
The sample preparation method does not seem to
matter in the case of peptide 1; the most intense ion
signals are metal adduct ions (Figure 2, Inset 1) having
relative intensities about the same for the two MALDI
methods. The adduction extent in solvent-based
MALDI is unexpectedly high, which may be rational-
ized by the use of the MBMmethod before desolution of
the analyte and matrix, although it is not obvious why
this should be the case. An additional weak signal [M
16] was observed when either method was employed.
Pure peptide 1 was examined using MALDI and ESI
(MS and MS/MS). The results indicated that peptide 1
is oxidized at Met35 (Supplementary Information). The
analyses reveal that this modification may not have
been caused during sample preparation but was al-
ready present in the purchased sample.
Overall, the MS/MS study (Supplementary Informa-
tion) of the peptides in Mix. 1 gave equivalent mass
spectra for peptides 2 and 3 by both methods. Fragmen-
tation of 3 was of somewhat poorer quality in the
solvent-free approach. Peptide 4 in Mix. 1 was readily
observed using the solvent-free method (Figure 2, Inset
4B) and gave interpretable MS/MS fragment ions, but
was not detected using the solvent-based method (Fig-
ure 2, Inset 4A). Pure 4 could be analyzed by either
method using MS/MS, but the results were not notable,
as might be expected for such a large molecule. Inter-
estingly, only N-terminal fragment ions, b7 and b23,
were observed, which precludes C-terminal informa-
tion being obtained.
The response factors for model mixtures of peptides
1 : 2 : 3 : 4 (Table 1) in molar ratios 3:3:3:1 (Mix. 2) and
secti
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represented in both methods. The mass resolution
was good and both protonation and metal adduct
formation were evident. Peptide 4 showed no inter-
pretable signals when the solvent-based preparation
method was used for either of these model mixtures
(Table 1). In addition, peptide 1 , where it represented
16.7% or 30% in Mix. 2 and 3, respectively, was not
appreciably detected in the solvent-based MALDI
approach (Table 1), which is in contrast to Mix. 1
where peptide 1 is present in 25% and readily ob-
served. Significantly higher detection of 1, along with
the significant increase of the total ion current in one
case (Supplementary Information) and the absence of
notable signal and lower total ion current in others,
seem to support a hot-spot phenomenon that arises in
the solvent-based MALDI method. Solvent-free
MALDI-MS and MS/MS analyses, on the other hand,
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Figure 2. Inset mass spectra of a molar 1:1:1
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1325.3 Da) and non--amyloid component of A
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3, peptide 3; Inset spectra 4, peptide 4; by (A) solv
mass spectra in the Supplementary Informationcharacterized low molecular weight peptide 1 andhigh molecular weight peptide 4 in all the mixtures
(Table 1). The cumulative results from this study indicate
that the dry (solvent-free) MALDI approach is generally
more reliable provided sufficient material is available.
Solvent-free MALDI requires more analyte than
the solvent-based method. For this reason it was
important to evaluate the sensitivity of the MBM
MALDI method (Exp. 3). This was followed through
by determining the amount of -amyloid (1-11), the
most soluble of the peptides studied, required to
obtain an MS/MS spectrum with good MASCOT
scores. By using a dilution method that continuously
halved the peptide concentration, it was determined
that solvent-free MBM method yielded readily inter-
pretable MS/MS spectra with 750 fmol but not 375
fmol of peptide (1-11) 2 (Supplementary Informa-
tion). It was therefore concluded that the MBM
method was sufficiently sensitive for many problems
1315 1326 1337 1348 1359 1370
Mass (m/z)
1.1E+4
20
40
60
80
100
%
 I
n
te
n
si
ty
13
25
.5
13
47
.5
13
63
.4
1315 1326 1337 1348 1359 1370
Mass (m/z)
8.7E+4
20
40
60
80
100
%
 I
n
te
n
si
ty
13
25
.5
13
63
.4
13
47
.4
[M
1-
1
1+
H
]+
[M
1-
1
1+
N
a]
+
[M
1-
1
1+
K
]+
[M
1-
1
1+
H
]+
[M
1-
1
1+
N
a]
+
[M
1-
1
1+
K
]+
4463.0 4487.4 4511.8 4536.2 4560.6 4585.0
Mass (m/z)
707.2
20
40
60
80
100
%
 I
n
te
n
si
ty
45
12
.0
4463.0 4487.4 4511.8 4536.2 4560.6 4585.0
Mass (m/z)
28.1
20
40
60
80
100
%
 I
n
te
n
si
ty
[M
1-
4
2+
H
]+
2 tesnI
4 tesnI
(A)
(B)
(A)
(B)
del peptide mixture with inherently different
olution), hydrophilic -amyloid (1-11; MWtheor
imer’s disease (NAC; MWtheor 3260.6 Da) and
des -amyloid (33-42; MWtheor 915.2 Da) and
eptide 1; Inset spectra 2, peptide 2; Inset spectra
ased and (B) solvent-free MALDI-MS (full scale
on).:1 mo
ous s
lzhe
pepti
a 1, p
ent-brelating to the analysis of peptides and proteins.
cted
1540 TRIMPIN AND DEINZER J Am Soc Mass Spectrom 2007, 18, 1533–1543Optimization Trials for the Solvent-Based MALDI
Analysis of Defined Peptide Mixtures
In principle, the analytical performance of the solvent-
based MALDI approach should improve by using a
solvent that dissolves the solubility-limited peptides 1
and 4 along with 2 and 3, however, finding such a
universal solvent is problematic, especially for -amy-
loid peptides. For example, -amyloid peptide (1-42)
has very low solubility and, thus, is only soluble in
solvents with low MS compatibility such as 1,1,1,3,3,3-
hexafluoro-2-propanal (HFIP) and sonication (10 min)
to a concentration of 1 mg mL1 [15]. A very recent
paper [16] evaluated the solubility degree of (1-42) to be
95% in HFIP and 83% in dimethyl sulfoxide compared
with MS compatible solvents with 6% in water (pH 7.4),
0% in ACN, 29% in 50% ACN:water, and 20% TFA. The
solubility degree was determined by dissolving 10 mg
3200 3240 3280 3320 3360 3400
Mass (m/z)
1868.8
3
2
59
.6
3
28
1
.6
3
29
7
.6
32
42
.6
3200 3240 3280 3320 3360 3400
Mass (m/z)
2453.3
32
59
.5
3
2
81
.5
33
24
.6
4
32
42
.5
32
16
.5
3
2
97
.5
[M
(N
A
C
)+
H
]+
[M
(N
A
C
)+
N
a
]+
[M
(N
A
C
)+
N
a+
K
-H
]+
[M
(N
A
C
)+
K
]+
[M
(N
A
C
)
+
 H
]+
[M
(N
A
C
)+
N
a
]+
[M
(N
A
C
)+
N
a
+
K
-H
]+
[M
(N
A
C
)+
K
]+
900 920 940 960 980 1000
Mass (m/z)
1071.9
9
53
.5
91
5
.5
9
6
9.
5
9
37
.5
99
3.
4
900 920 940 960 980 1000
Mass (m/z)
300.7
20
40
60
80
100
%
 I
n
te
n
si
ty
9
15
.5
9
75
.4
9
5
3.
4
[M
(3
3-
4
2)
+
H
]+
[M
(3
3-
4
2)
+
N
a
]+
[M
(3
3-
4
2)
+
2N
a
-H
]+
[M
(3
3-
4
2)
+
H
]+
[M
(3
3-
4
2)
+
K
]+
[M
(3
3-
4
2)
+
N
a
+
K
-H
]+
20
40
60
80
100
%
 I
n
te
n
si
ty
20
40
60
80
100
%
 I
n
te
n
si
ty
20
40
60
80
100
%
 I
n
te
n
si
ty
1 tesnI
3 tesnI
9
15
.5
[M
(3
3-
4
2,
ox
)+
H
]+
[M
(3
3-
4
2,
ox
)+
H
]+
[M
(3
3-
4
2,
ox
)+
N
a
]+
[M
(3
3-
4
2)
+
K
]+
[M
(3
3-
4
2,
ox
)+
N
a]
+
[M
(3
3-
4
2,
ox
)+
2N
a
-H
]+
(A)
(B)
(A)
(B)
Figure 3. Mass spectra (full scale mass spectra
mixtures with molar ratios for peptides 1:2:3:4
MALDI-MS and ACN 0.1% TFA. Inset spectra
respectively. Contrary to predictions, only 4was
composition, and then only with low signal i
indicating that 4 underwent oxidation during so
50% and 1 at 16.7%, these peptides were barel
equals 10% 1 and 30% 3, peptide 4 was not deteof purified 4 in 1 mL of the respective solvent followedby centrifugation, supernatant removal, and repetition
till constant weight was achieved.
Dissolving Mix. 2 (10% of 4) and Mix. 3 (50% of 4), in
99.9% ACN 0.1% TFA makes peptide 4 modestly acces-
sible only in Mix. 3 (Figure 3, Inset 4A). Although
according to study [16], 4 is not soluble in ACN; this
solvent nevertheless improved the detection. However,
before dissolving 4, it was homogenized with matrix to
give a representative MBM sample as is evident by the
successful solvent-free MALDI analysis. Possibly be-
cause of the prior homogenization, the HCCA matrix,
which is readily soluble in ACN, aided the desolution of
the -amyloid peptide. These factors may account for
the successful detection of 4. In Mix. 3, the overall signal
intensity was not as abundant as it was for any of the
mixtures using solvent-free MALDI. Mix. 2, however,
gave no appreciable signal for peptide 4 (Figure 3, Inset
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Supplementary Information section) of peptide
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ity. A signal at M  16 Da is also observed
-based MALDI-MS. Even though 4 is present at
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y de4B). A mass spectrum was not obtained when the molar
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power. Peptide 4 is possibly lost through adhesion to
the wall of the tube, however, insufficient homogeneity
(segregation) might be a cause, too.
In addition to the molecular ion signal for peptide
4, a signal was also observed for M(1-42)  16 Da in the
ACN dissolved sample (Figure 3, Inset 4A) suggest-
ing that 4 underwent oxidation during solvent-based
sample preparation or analysis. The most likely site
of oxidation is at Met35 located in the hydrophobic
membrane-containing C-terminal region of the pro-
tein. MS/MS fragment ions from peptide 4 do not
include amino acid position Met35 so that it was not
possible to confirm oxidation at this residue. Further
studies, but on pure peptide 1, revealed that Met
oxidation increases in either pure water or pure ACN
(Supplementary Information), however the effect was
greater in ACN.
Detection of 1 in the 3:3:3:1 mixture corresponding to
30% 1 by solvent-based MALDI was not significantly
better than in the 1:1:1:3 mixture corresponding to 17% 1
(Figure 3, Inset 1). The signal intensity increased, but
predominantly for the [M  K] ion and not the proton-
ated ion. Overall, the small solubility-limited peptide 1
was still barely detected in either of the two mixtures. In
addition, the mass spectra of 1 dissolved in water at 37 °C
for 24 hwas also of poorer quality, based on a significantly
reduced signal intensity of the non-oxidized 1, in compar-
ison with the mass spectra obtained right after dissolving
the sample. This shows that pure sample 1 is sensitive to
solvent in the vial and not only to sample conditions used
in solvent-based MALDI analysis. These results on pure 1
assist in explaining the solvent-based results of peptide 1
within Mix. 1 to 3, suggesting that, in addition to the
hotspots on the MALDI plate, sample loss and undesired
reaction in the vial also occur. These results indicate that
optimization trials in solvent-based MALDI are also lim-
ited for low molecular weight peptides.
For both 1 and 4 there is evidence for sample loss and
side-reactions occurring upon use of solvent. Adsorp-
tive sample losses of extracts can also be a problem with
even soluble analytes [17, 18]. Problems such as insuf-
ficient homogeneity and sample loss are not encoun-
tered when the dry MBM MALDI method is used
because the dry analyte is effectively homogenized with
the matrix in the vial to give a more representative
sample on the MALDI plate (Table 1). Both the higher
signal intensity and the absence of side-products
formed during MALDI sample preparation of 1 and 4
show clear advantages of the solvent-free approach
relative to a solvent-based method. Similar results were
previously observed [3].
Automated MALDI-MS and MS/MS Analysis
of Defined Peptide Mixtures
Automated MALDI-MS and MS/MS studies of the four
peptides, Mix. 2 and 3, were used to compare thesolvent-free MBM and solvent-based (50:50 ACN:water
0.1% TFA) methods. The data were interpreted using
the MASCOT program (Table 2). All four peptides
scored high based on solvent-free MBM MALDI data
from both mixtures, but only the soluble peptides 2 and
3 scored high enough to identify them using data from
the solvent-based experiment. The observed ion scores
for the soluble peptides 2 and 3 were similar for both
MALDI methods. In the solvent-based MALDI method,
the most hydrophilic low molecular weight peptide 2
(grand average of hydropathicity (GRAVY) score
1.782, Table 2) is easily detected and, in fact, greatly
over-represented in comparison with all the other more
hydrophobic peptides. The detection of the -amyloid
peptides 2 and 3 coupled with the failure of detecting 1
and 4 using the traditional solvent-based MALDI cor-
relates well with the solubility of each peptide but not
with the GRAVY score. The results from the solvent-
free MALDI analysis followed the same trend but
differences in signal intensities were not as pronounced,
indicating that solubility and hydrophobicity are less
significant in non traditional MALDI. These results are
in accord with studies of bacteriorhodopsin [19], in
which the two most hydrophilic peptides (GRAVY
scores 0.265 and 0.038) are generally the base signal
in any of the mass spectra; the observed over-represen-
tation is less significant in solvent-free results.
Response Assessment for MALDI Analysis
of Defined Peptide Mixtures
The solvent-free MBMmethod not only detected intrac-
table analyte 4 but also showed an increase in the signal
intensity with increasing molar ratio of this peptide in
the mixtures (Supplementary Information). The ion
signal cluster areas of the individual peptides inclusive
of H, Na, K ions were summed and their contribu-
tions determined relative to the four peptides in each
Mix. 1 to 3, and reported as response factors (Table 1).
The response factors, which are the individual peak
areas divided by the sum of peak areas of all of the
peptides in the mixture, represent departures from the
expected response. For example, a response factor of 1
would be the expected response; response factors 1
are considered over-representation and 1, under-rep-
resentation in the analysis. In the case of Mix. 2 (Table
1), the molar ratio corresponds to 10% of 4 and 30% each
of the other three peptides. The ratio 0.1:9.19:0.7:0 from
solvent-based MALDI data corresponds to response
factors of 0.03:3.07:0.23:n.d. By solvent-free MALDI, a
ratio of 2.11:6.75:0.79:0.35 was observed that corre-
sponds to response factors of 0.73:2.25:0.26:0.25. Hence,
the small insoluble peptide 1 is under-represented by
97% in the solvent-based approach and 27% in the dry
MALDI experiment. The small soluble peptide 2 is
greatly over-represented by 207% (solvent-based)
and 125% (solvent-free). The soluble high-molecular
weight peptide 3 is under-represented by 77%
1542 TRIMPIN AND DEINZER J Am Soc Mass Spectrom 2007, 18, 1533–1543(solvent-based) and 74% (solvent-free), and the insol-
uble high molecular weight peptide 4 is under-
represented by 75% (solvent-free) but not observed
in solvent-based. If detected, both soluble and insol-
uble high molecular weight peptides are under-rep-
resented between 77% and 74%, indicating that both
methods underlie similar desorption/ionization pro-
cesses if proper sample preparation had been em-
ployed, which is not the case for the combination
insoluble 4 and solvent-based MALDI.
Comparing the results of solvent-based and solvent-
free MALDI analytical approaches, it becomes clear that
the same trends are observed, however, the results from
the solvent-based approach are more extreme, e.g., not
all peptides are detected and the response factors for
detected peptides range between 9% and 207%. In
contrast, the values obtained for the solvent-free
method are within the range 75% to 125% and all
peptides were detected. Similar trends are observed for
Mix. 1 and 3 (Table 1).
Response Assessment for MALDI Analysis
of Insoluble Peptides
Clearly, the use of solvent-free MALDI analysis for the
small hydrophobic peptide 1 is more reliably repre-
sented than when the solvent-based procedure is used,
which is also evident by the lower variability in total ion
current. The different behavior in the analysis of 4
exemplifies the problem of quantitation by MALDI-MS
(Table 1). An increase in the individual peak areas of 4
are observed correctly (0.35, 0.39, and 0.48) in that they
follow the weight percentage trend of 4 (10%, 24.9%,
49.3%), but the response factors (0.35, 0.39, and 0.16) are
influenced by the response factors of all the peptides
present in a mixture. The inaccuracy of response factors
of peptide 4 is probably related to a combination of the
total ion current (Table 1, Figure in Supplementary
Information) and the sample preparation strategy of
assuring identical comparison between both sample
preparation methods, which is achieved at the expense
of small systematic errors comparing results between
Mix. 1 to 3 within each method. Despite variations in
the response factors, the signal increase with increasing
amounts of 4 in the solvent-free spectra (Table 1) is
advantageous since solvent-based MALDI did not al-
low the detection of 4 at all. The variable response
factors demonstrate that quantitation in MALDI exper-
iments are complicated as noted previously, e.g., [20],
although relative responses (Table 1) of peptides in the
solvent-free method deviate less, which is a positive
attribute for this approach.
Conclusions
Metal cation adduction was shown to be advantageous
as it provides reliable detection of the more hydropho-
bic peptides (33-42) 1 (model peptide mixtures) andT17-42 (tryptic digest of peptide 4); shorter, very insolu-
ble amyloid peptides encompassing aa residues 17 to 42
have been observed in amyloid deposits related to AD
in addition to -amyloid peptides (1-42) and (1-40) [21].
The solvent-free approach increases metal adduction,
which can also be a disadvantage because it tends to
complicate the interpretation of the mass spectra as well
as distributing the ion signal over several mass-to-
charge values. The MBM method holds promise for
analyzing insoluble peptides such as those obtained
frommembrane proteins and digests in which digestion
is limited or incomplete. In this study, it is demon-
strated that both hydrophobic and hydrophilic peptides
over a wide mass range can be analyzed by the solvent-
free MALDI-MS approach, thus expanding the reper-
toire of the MALDI method to protein/peptide analyses
for which ESI-MS has traditionally been better suited
[22–24]. It is shown that the ability to detect the peptides
used in this study is more closely related to solubility
than to the GRAVY index. This is particularly the case
for the amphiphilic peptide 4, which had the second
highest hydrophilic GRAVY score of the four peptides
used in this study, but very low solubility and high
aggregation propensity [5–7, 13, 15, 16, 25].
The lower degree of discrimination between hydro-
philic and hydrophobic peptides by the MBM MALDI
method is an obvious advantage in obtaining quantita-
tively more representative spectra of all peptides
present in the sample. In contrast to the solvent-based
method, peptides from trypsin autoproteolysis essen-
tially were not observed with the solvent-free MBM
method, which correlates with the fact that this method
gives more reliable quantitative results since the pro-
tease is only employed in trace amounts compared to
the peptide 4. These studies show that the MBM
MALDI approach can produce more representative
information about peptides present in a sample regard-
less of whether they are hydrophobic, hydrophilic,
soluble, or insoluble, and present in large or small
relative amounts. The result, as shown in this study, can
be improved sequence coverage. In addition, without
the use of solvents, chemical modifications promoted in
situ, such as oxidation, are less likely. For example, the
reaction with APP at Met706, corresponding to Met35 of
A (1-42), plays a critical role in induced oxidative
stress and neurotoxicity related to Alzheimer’s disease
[25] and is therefore an analytical challenge as it can
occur in vivo and during sample preparation for MS
analysis. Clearly, when analyzing peptide samples,
oxidized methionine(s) should not arise from the sam-
ple preparation procedure, and as observed here, the
dry MALDI approach circumvents this problem. This
characteristic in particular may be important for study-
ing the progression of AD.
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